Market Closed -
NSE India S.E.
05:17:53 21/06/2024 pm IST
|
5-day change
|
1st Jan Change
|
6,011
INR
|
+0.68%
|
|
-1.21%
|
+3.68%
|
Fiscal Period: March |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
2027
|
---|
Capitalization
1 |
5,16,741
|
7,49,317
|
7,14,500
|
7,67,655
|
10,24,969
|
10,00,688
|
-
|
-
|
Enterprise Value (EV)
1 |
5,13,012
|
7,45,052
|
7,03,980
|
7,19,330
|
9,60,383
|
9,11,922
|
8,70,642
|
8,29,911
|
P/E ratio
|
26.6
x
|
39.2
x
|
30.4
x
|
17.1
x
|
18.4
x
|
18.1
x
|
17.6
x
|
20.6
x
|
Yield
|
0.8%
|
0.55%
|
0.7%
|
0.87%
|
0.65%
|
0.75%
|
0.69%
|
0.78%
|
Capitalization / Revenue
|
2.96
x
|
3.95
x
|
3.33
x
|
3.11
x
|
3.66
x
|
3.33
x
|
3.15
x
|
3.14
x
|
EV / Revenue
|
2.94
x
|
3.93
x
|
3.28
x
|
2.92
x
|
3.43
x
|
3.04
x
|
2.74
x
|
2.6
x
|
EV / EBITDA
|
11
x
|
15.7
x
|
13.7
x
|
11.1
x
|
12.1
x
|
10.9
x
|
10.1
x
|
10.8
x
|
EV / FCF
|
20.5
x
|
28.7
x
|
52.3
x
|
15.1
x
|
33.1
x
|
19.5
x
|
18.2
x
|
16.8
x
|
FCF Yield
|
4.87%
|
3.48%
|
1.91%
|
6.61%
|
3.02%
|
5.12%
|
5.49%
|
5.95%
|
Price to Book
|
3.33
x
|
4.29
x
|
3.76
x
|
3.33
x
|
3.63
x
|
3.06
x
|
2.68
x
|
2.42
x
|
Nbr of stocks (in thousands)
|
1,65,776
|
1,65,940
|
1,65,954
|
1,66,105
|
1,66,522
|
1,66,540
|
-
|
-
|
Reference price
2 |
3,117
|
4,516
|
4,305
|
4,622
|
6,155
|
6,009
|
6,009
|
6,009
|
Announcement Date
|
09/06/20
|
14/05/21
|
19/05/22
|
10/05/23
|
07/05/24
|
-
|
-
|
-
|
Fiscal Period: March |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
2027
|
---|
Net sales
1 |
1,74,600
|
1,89,722
|
2,14,391
|
2,46,697
|
2,80,111
|
3,00,318
|
3,18,177
|
3,18,621
|
EBITDA
1 |
46,431
|
47,480
|
51,400
|
64,559
|
79,481
|
84,035
|
85,897
|
77,173
|
EBIT
1 |
28,470
|
31,977
|
34,277
|
52,057
|
64,781
|
67,650
|
68,202
|
59,916
|
Operating Margin
|
16.31%
|
16.85%
|
15.99%
|
21.1%
|
23.13%
|
22.53%
|
21.44%
|
18.8%
|
Earnings before Tax (EBT)
1 |
18,032
|
28,324
|
32,298
|
60,485
|
72,010
|
73,198
|
74,500
|
63,708
|
Net income
1 |
19,498
|
19,149
|
23,568
|
45,073
|
55,779
|
54,862
|
56,070
|
48,947
|
Net margin
|
11.17%
|
10.09%
|
10.99%
|
18.27%
|
19.91%
|
18.27%
|
17.62%
|
15.36%
|
EPS
2 |
117.4
|
115.1
|
141.7
|
270.9
|
334.6
|
332.3
|
341.1
|
292.0
|
Free Cash Flow
1 |
24,995
|
25,962
|
13,448
|
47,552
|
29,030
|
46,713
|
47,783
|
49,420
|
FCF margin
|
14.32%
|
13.68%
|
6.27%
|
19.28%
|
10.36%
|
15.55%
|
15.02%
|
15.51%
|
FCF Conversion (EBITDA)
|
53.83%
|
54.68%
|
26.16%
|
73.66%
|
36.52%
|
55.59%
|
55.63%
|
64.04%
|
FCF Conversion (Net income)
|
128.19%
|
135.58%
|
57.06%
|
105.5%
|
52.04%
|
85.15%
|
85.22%
|
100.96%
|
Dividend per Share
2 |
25.00
|
25.00
|
30.00
|
40.00
|
40.00
|
44.94
|
41.37
|
46.77
|
Announcement Date
|
09/06/20
|
14/05/21
|
19/05/22
|
10/05/23
|
07/05/24
|
-
|
-
|
-
|
Fiscal Period: March |
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
2025 Q3
|
2025 Q4
|
---|
Net sales
1 |
53,197
|
54,368
|
52,154
|
63,057
|
67,700
|
63,152
|
67,384
|
68,802
|
72,148
|
71,138
|
72,200
|
74,516
|
75,293
|
75,162
|
EBITDA
1 |
12,018
|
12,980
|
9,238
|
18,944
|
20,562
|
15,955
|
20,450
|
19,915
|
20,180
|
18,174
|
19,504
|
20,727
|
19,939
|
19,592
|
EBIT
1 |
9,042
|
8,743
|
6,188
|
15,818
|
17,291
|
12,800
|
16,867
|
16,126
|
16,410
|
14,497
|
16,067
|
17,011
|
16,775
|
16,075
|
Operating Margin
|
17%
|
16.08%
|
11.86%
|
25.09%
|
25.54%
|
20.27%
|
25.03%
|
23.44%
|
22.74%
|
20.38%
|
22.25%
|
22.83%
|
22.28%
|
21.39%
|
Earnings before Tax (EBT)
1 |
9,709
|
2,483
|
14,655
|
16,111
|
16,346
|
13,291
|
18,463
|
19,134
|
18,257
|
16,052
|
16,046
|
17,269
|
16,481
|
16,135
|
Net income
1 |
7,065
|
875
|
11,876
|
11,128
|
12,471
|
9,601
|
14,025
|
14,800
|
13,789
|
13,098
|
12,035
|
12,952
|
12,361
|
12,101
|
Net margin
|
13.28%
|
1.61%
|
22.77%
|
17.65%
|
18.42%
|
15.2%
|
20.81%
|
21.51%
|
19.11%
|
18.41%
|
16.67%
|
17.38%
|
16.42%
|
16.1%
|
EPS
|
42.48
|
5.260
|
71.40
|
66.89
|
74.95
|
57.68
|
84.22
|
88.78
|
82.68
|
78.53
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
28/01/22
|
19/05/22
|
28/07/22
|
28/10/22
|
25/01/23
|
10/05/23
|
26/07/23
|
27/10/23
|
30/01/24
|
07/05/24
|
-
|
-
|
-
|
-
|
Fiscal Period: March |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
2027
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
3,729
|
4,265
|
10,520
|
48,325
|
64,586
|
88,766
|
1,30,047
|
1,70,777
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
24,995
|
25,962
|
13,448
|
47,552
|
29,030
|
46,713
|
47,783
|
49,420
|
ROE (net income / shareholders' equity)
|
13.2%
|
11.6%
|
13%
|
21.4%
|
21.6%
|
17.7%
|
15.7%
|
12.2%
|
ROA (Net income/ Total Assets)
|
8.52%
|
7.69%
|
8.39%
|
14.7%
|
15.7%
|
12.8%
|
11.8%
|
9.55%
|
Assets
1 |
2,28,823
|
2,48,866
|
2,81,073
|
3,07,340
|
3,55,745
|
4,27,434
|
4,73,956
|
5,12,645
|
Book Value Per Share
2 |
935.0
|
1,052
|
1,145
|
1,387
|
1,694
|
1,966
|
2,245
|
2,483
|
Cash Flow per Share
2 |
180.0
|
215.0
|
169.0
|
354.0
|
272.0
|
396.0
|
414.0
|
385.0
|
Capex
1 |
4,846
|
9,741
|
14,660
|
11,323
|
16,403
|
16,310
|
16,353
|
16,910
|
Capex / Sales
|
2.78%
|
5.13%
|
6.84%
|
4.59%
|
5.86%
|
5.43%
|
5.14%
|
5.31%
|
Announcement Date
|
09/06/20
|
14/05/21
|
19/05/22
|
10/05/23
|
07/05/24
|
-
|
-
|
-
|
Last Close Price
6,009
INR Average target price
6,119
INR Spread / Average Target +1.84% Consensus |
1st Jan change
|
Capi.
|
---|
| +51.63% | 796B | | +41.51% | 628B | | -5.10% | 358B | | +19.90% | 331B | | +9.95% | 301B | | +17.66% | 244B | | +3.39% | 228B | | +10.75% | 214B | | +6.99% | 165B |
Other Pharmaceuticals
|